Tibolone vs combined HT
Breast cancer; women without previous breast cancer (all doses) · postmenopausal women with or without vasomotor symptoms
It is very uncertain whether tibolone changes breast cancer; women without previous breast cancer (all doses) compared with combined HT (very low certainty).
1 finding from 1 review
- Short‐term and long‐term effects of tibolone in postmenopausal women 2016 · Cochrane Headline outcomes onlyOR 1.69 [0.78, 3.67]5 studies · 4835 participantsVery low